Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.

Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhäuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS.

BJU Int. 2013 Jul;112(2):E51-8. doi: 10.1111/bju.12215.

2.

Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.

Zehnder P, Studer UE, Daneshmand S, Birkhäuser FD, Skinner EC, Roth B, Miranda G, Burkhard FC, Cai J, Skinner DG, Thalmann GN, Gill IS.

BJU Int. 2014 Apr;113(4):554-60. doi: 10.1111/bju.12520. Epub 2014 Jan 29.

3.

Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.

Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC.

Eur Urol. 2011 Nov;60(5):946-52. doi: 10.1016/j.eururo.2011.07.012. Epub 2011 Jul 14.

PMID:
21802833
4.

Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.

Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhäuser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG.

J Urol. 2011 Oct;186(4):1261-8. doi: 10.1016/j.juro.2011.06.004. Epub 2011 Aug 17.

PMID:
21849183
5.

Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.

Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, Thüroff JW.

BJU Int. 2009 Aug;104(3):331-5. doi: 10.1111/j.1464-410X.2009.08403.x. Epub 2009 Feb 11.

6.

Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.

May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ.

Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19.

PMID:
21246405
7.

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.

Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE.

J Urol. 2008 Mar;179(3):873-8; discussion 878. doi: 10.1016/j.juro.2007.10.076. Epub 2008 Jan 25.

PMID:
18221953
8.
9.

Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.

Jensen JB, Ulhøi BP, Jensen KM.

Int J Urol. 2012 Jan;19(1):39-47. doi: 10.1111/j.1442-2042.2011.02887.x. Epub 2011 Nov 3.

10.

Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study.

Abol-Enein H, Tilki D, Mosbah A, El-Baz M, Shokeir A, Nabeeh A, Ghoneim MA.

Eur Urol. 2011 Sep;60(3):572-7. doi: 10.1016/j.eururo.2011.05.062. Epub 2011 Jun 12.

PMID:
21684070
11.

Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.

Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W.

BJU Int. 2012 Nov;110(9):1317-23. doi: 10.1111/j.1464-410X.2012.11133.x. Epub 2012 Apr 13.

12.

Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.

Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF.

BJU Int. 2013 Jan;111(1):74-84. doi: 10.1111/j.1464-410X.2012.11356.x. Epub 2012 Jul 19.

13.

Lymphadenectomy in bladder cancer: how high is "high enough"?

Stein JP.

Urol Oncol. 2006 Jul-Aug;24(4):349-55.

PMID:
16818190
14.

[Clinical significance of radical cystectomy with extended lymphadenectomy].

Liu XZ, Shen KH, Yan XD, Yu W, Guo YL, He Q, Xi ZJ.

Beijing Da Xue Xue Bao. 2011 Aug 18;43(4):574-8. Chinese.

15.
16.

Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.

Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG.

J Urol. 2009 May;181(5):2052-8; discussion 2058-9. doi: 10.1016/j.juro.2009.01.020. Epub 2009 Mar 14.

PMID:
19286213
17.

Retrospective review and long-term follow-up of radical cystectomy in a developing country.

Gaitonde K, Goyal A, Nagaonkar S, Patil N, Singh DR, Srinivas V.

BJU Int. 2002 Mar;89 Suppl 1:57-61.

18.

Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.

Koga F, Kihara K, Yoshida S, Yokoyama M, Saito K, Masuda H, Fujii Y, Kawakami S.

BJU Int. 2012 Mar;109(6):860-6. doi: 10.1111/j.1464-410X.2011.10425.x. Epub 2011 Aug 19.

19.

Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy.

Kim YB, Hong SJ, Yang SC, Cho JH, Choi YD, Kim GE, Rha KH, Han WK, Cho NH, Oh YT.

J Korean Med Sci. 2010 Jun;25(6):835-40. doi: 10.3346/jkms.2010.25.6.835. Epub 2010 May 24.

20.

Supplemental Content

Support Center